Correlation Between PSI Software and Hisamitsu Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both PSI Software and Hisamitsu Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PSI Software and Hisamitsu Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PSI Software AG and Hisamitsu Pharmaceutical Co, you can compare the effects of market volatilities on PSI Software and Hisamitsu Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PSI Software with a short position of Hisamitsu Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of PSI Software and Hisamitsu Pharmaceutical.

Diversification Opportunities for PSI Software and Hisamitsu Pharmaceutical

-0.29

Correlation Coefficient

PSI Software  Hisamitsu Pharmaceutical

Very good diversification

The 3 months correlation between PSI and Hisamitsu is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding PSI Software AG and Hisamitsu Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hisamitsu Pharmaceutical and PSI Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PSI Software AG are associated (or correlated) with Hisamitsu Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hisamitsu Pharmaceutical has no effect on the direction of PSI Software i.e., PSI Software and Hisamitsu Pharmaceutical go up and down completely randomly.

Pair Corralation between PSI Software and Hisamitsu Pharmaceutical

Assuming the 90 days trading horizon PSI Software AG is expected to under-perform the Hisamitsu Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, PSI Software AG is 1.92 times less risky than Hisamitsu Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Hisamitsu Pharmaceutical Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,380  in Hisamitsu Pharmaceutical Co on October 1, 2024 and sell it today you would earn a total of  120.00  from holding Hisamitsu Pharmaceutical Co or generate 5.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PSI Software AG  vs.  Hisamitsu Pharmaceutical Co

PSI Software AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PSI Software AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, PSI Software is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Hisamitsu Pharmaceutical

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Hisamitsu Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Hisamitsu Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with PSI Software and Hisamitsu Pharmaceutical

The main advantage of trading using opposite PSI Software and Hisamitsu Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PSI Software position performs unexpectedly, Hisamitsu Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hisamitsu Pharmaceutical will offset losses from the drop in Hisamitsu Pharmaceutical's long position.

The idea behind PSI Software AG and Hisamitsu Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.